Remote follow-up for low-risk blood clot patients
Part of Heart & circulation clinical trials.
This study tests whether remote care (check-ins by phone/video or other remote support) can safely help people with a low-risk deep vein thrombosis or pulmonary embolism after an ER diagnosis. It may improve follow-up and support while reducing the need for frequent in-person visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed in the emergency room with a blood clot: deep vein thrombosis or pulmonary embolism, and it was judged “low risk.”
- You have health coverage/social protection and can receive study follow-up through that system.
- You are not already being treated for the clot, and doctors do not suspect a heparin-related low platelet problem.
- You do not have active bleeding or a high risk of bleeding, severe kidney failure, cancer, or other major medical issues that would complicate care.
- You can use the internet for remote visits and have a primary care doctor to coordinate care.
- You can understand the study (language/mental ability) and can read or write; you are not under legal protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who have had a blood clot in their leg or lung to learn more about their health over time. It helps doctors understand how to better care for people with blood clots.
This study tests if using a smartphone app or tablet helps doctors and patients work together to prevent or manage blood clots in the legs or lungs. It is for adults in the hospital who have or are at high risk of a blood clot.
This study uses smart technology to help manage the risk of blood clots (called VTE) after you leave the hospital. It focuses on giving you tools to stay safe and healthy during your recovery.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This trial tests whether using smart technology, like apps or devices, can improve care for people with pulmonary thromboembolism (blood clots in the lungs). It aims to help patients manage their condition better and recover more smoothly.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
Hear when a new Thromboembolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.